In cancer, a patient is considered a survivor from the time of initial diagnosis until the end of life. With improvements in early diagnosis and treatment, the number of cancer survivors (CS) has grown considerably and includes: (1) Patients cured and free from cancer who may be at risk of late-onset cancer therapy-related cardiovascular toxicity (CTR-CVT); (2) Patients with long-term control of not-curable cancers in whom CTR-CVT may need to be addressed. This paper highlights the importance of the cancer care continuum, of a patient-centered approach and of a prevention-oriented policy. The ultimate goal is a personalized care of CS, achievable only through a multidisciplinary-guided survivorship care plan, one that replaces the fragmented management of current healthcare systems. Collaboration between oncologists and cardiologists is the pillar of a framework in which primary care providers and other specialists must be engaged and in which familial, social and environmental factors are also taken into account.
Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals / Bisceglia, Irma; Canale, Maria Laura; Silvestris, Nicola; Gallucci, Giuseppina; Camerini, Andrea; Inno, Alessandro; Camilli, Massimiliano; Turazza, Fabio Maria; Russo, Giulia; Paccone, Andrea; Mistrulli, Raffaella; De Luca, Leonardo; Di Fusco, Stefania Angela; Tarantini, Luigi; Lucà, Fabiana; Oliva, Stefano; Moreo, Antonella; Maurea, Nicola; Quagliariello, Vincenzo; Ricciardi, Giuseppina Rosaria; Lestuzzi, Chiara; Fiscella, Damiana; Parrini, Iris; Racanelli, Vito; Russo, Antonio; Incorvaia, Lorena; Calabrò, Fabio; Curigliano, Giuseppe; Cinieri, Saverio; Gulizia, Michele Massimo; Gabrielli, Domenico; Oliva, Fabrizio; Colivicchi, Furio. - In: FRONTIERS IN CARDIOVASCULAR MEDICINE. - ISSN 2297-055X. - 10:(2023), pp. 122366001-122366014. [10.3389/fcvm.2023.1223660]
Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals
Racanelli, Vito;
2023-01-01
Abstract
In cancer, a patient is considered a survivor from the time of initial diagnosis until the end of life. With improvements in early diagnosis and treatment, the number of cancer survivors (CS) has grown considerably and includes: (1) Patients cured and free from cancer who may be at risk of late-onset cancer therapy-related cardiovascular toxicity (CTR-CVT); (2) Patients with long-term control of not-curable cancers in whom CTR-CVT may need to be addressed. This paper highlights the importance of the cancer care continuum, of a patient-centered approach and of a prevention-oriented policy. The ultimate goal is a personalized care of CS, achievable only through a multidisciplinary-guided survivorship care plan, one that replaces the fragmented management of current healthcare systems. Collaboration between oncologists and cardiologists is the pillar of a framework in which primary care providers and other specialists must be engaged and in which familial, social and environmental factors are also taken into account.File | Dimensione | Formato | |
---|---|---|---|
2023 Front Cardiovasc Med_compressed.pdf
accesso aperto
Tipologia:
Versione editoriale (Publisher’s layout)
Licenza:
Creative commons
Dimensione
643.66 kB
Formato
Adobe PDF
|
643.66 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione